20
Participants
Start Date
November 28, 2005
Primary Completion Date
July 24, 2007
Study Completion Date
September 2, 2007
Leuprolide acetate
"Leuprolide acetate (Lupron Depot®) 3.75-mg intramuscular injection~Leuprolide is a widely used gonadotropin-releasing hormone agonist (GnRHa) that is indicated for treatment of endometriosis, uterine fibroids, precocious puberty, and prostate cancer, and is used off-label for in-vitro fertilization and premenstrual syndrome. In this protocol, leuprolide will be administered once during the mid-luteal phase of the menstrual cycle at a dose routinely used for treatment of endometriosis and uterine fibroids in women."
Massachusetts General Hospital, Boston
Endocrine Research Society
OTHER
Massachusetts General Hospital
OTHER